Diaceutics PLC - Belfast-based testing laboratories company - Posts revenue of £19.5 million for 2022, up 40% from £13.9 million in 2021. Pretax profit is £564,000, up from £462,000, as operating profit increases to £575,000 from £550,000 a year earlier. Administrative expenses increase to £16.3 million from £11.9 million. Earnings before interest, tax, depreciation and amortisation amounts to £3.6 million, up from £2.3 million. Order book stands at £16.9 million at year-end, compared to £1.8 million a year earlier.

Chief Executive Officer Peter Keeling says: ‘We have delivered another year of significant financial and operational progress, increasing revenue materially ahead of initial expectations, driven by the demand from our pharma customers for our expanded offering of platform solutions. As Diaceutics continues to expand its platform offering and execute against its strategic goals, we look to the future with confidence as we work to become the primary partner for pharma or biotechs launching a precision medicine.’

Current stock price: 103.40 pence each, up 2.9% on Monday afternoon in London

12-month change: down 6.9%

Copyright 2023 Alliance News Ltd. All Rights Reserved.